HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors-Reference-Cited by-同舟云学术

HuR in pheochromocytomas and paragangliomas - overexpression in verified malignant tumors

Published:2016-06-30 Issue:9 Volume:124 Page:757-763
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:APMIS

Author:

Leijon Helena¹,Salmenkivi Kaisa¹,Heiskanen Ilkka²,Hagström Jaana¹³,Louhimo Johanna²,Heikkilä Päivi¹,Ristimäki Ari¹⁴,Paavonen Timo⁵⁶,Metso Saara⁷⁶,Mäenpää Hanna⁸,Haglund Caj²⁹,Arola Johanna¹

Affiliation:

1. Department of Pathology; University of Helsinki and Helsinki University Hospital; Helsinki Finland

2. Department of Surgery; University of Helsinki and Helsinki University Hospital; Helsinki Finland

3. Department of Oral Pathology; University of Helsinki and Helsinki University Hospital; Helsinki Finland

4. Genome-Scale Biology; Research Programs Unit; University of Helsinki; Helsinki Finland

5. Department of Pathology; Fimlab Laboratories; Tampere University Hospital; Tampere Finland

6. School of Medicine; University of Tampere; Tampere Finland

7. Department of Internal Medicine; Tampere University Hospital; Tampere Finland

8. Department of Oncology; University of Helsinki and Helsinki University Hospital; Helsinki Finland

9. Translational Cancer Biology; Research Programs Unit; University of Helsinki; Helsinki Finland

Funder

Finnish Awarded Special State Subsidy

EVO

Finnish Cancer Foundation

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Reference28 articles.

1. Hereditary paraganglioma targets diverse paraganglia;Baysal;J Med Genet,2002

2. Malignant pheochromocytoma: a review;Harari;Am J Surg,2011

3. Histopathology of benign versus malignant sympathoadrenal paragangliomas: clinicopathologic study of 120 cases including unusual histologic features;Linnoila;Hum Pathol,1990

4. Pheochromocytoma of the Adrenal gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases;Thompson;Am J Surg Pathol,2002

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Predictors of Metastatic Potential in Paragangliomas to Develop a Prognostic Score (PSPGL);Journal of the Endocrine Society;2024-05-07

2. Genotype-phenotype relations of the von Hippel-Lindau tumor suppressor inferred from a large-scale analysis of disease mutations and interactors;PLOS Computational Biology;2019-04-03

3. COPPS, a composite score integrating pathological features, PS100 and SDHB losses, predicts the risk of metastasis and progression-free survival in pheochromocytomas/paragangliomas;Virchows Archiv;2019-03-13

4. Genotype-Phenotype Relations of the von Hippel-Lindau Tumor Suppressor Inferred from a Large-Scale Analysis of Disease Mutations and Interactors;2018-08-31

5. Downregulation of HuR Inhibits the Progression of Esophageal Cancer through Interleukin-18;Cancer Research and Treatment;2018-01-15